Skip to content

Medical-device intelligence

LSR: Reagent, Borrelia Serological Reagent

FDA product code LSR: Reagent, Borrelia Serological Reagent. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LSR
FDA device name
Reagent, Borrelia Serological Reagent
Device class
2
Regulation number
866.3830
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

112 clearance records and 5 recall records in the covered releases, across 45 source company names and 1 product codes. Dated history runs from Aug 25, 1987 to Jul 10, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202511
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202610
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LSR · Reagent, Borrelia Serological Reagent1125

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

117 matching records
Device / recordCompany in FDA recordSourceSource date
BOSTON BIOMEDICA, INC. BORRELIA BURGDORFERI IGM AND IGGK032713 · LSRBoston Biomedica, Inc.510(k)Nov 24, 2003FDA decision date
IMMUNETICS C6 LYME ELISA KITK003754 · LSRImmunetics, Inc.510(k)May 10, 2001FDA decision date
QUANTA LITE LYME B. BURGDORFERI IGG/IGM ELISA KITK994004 · LSRInova Diagnostics, Inc.510(k)Jan 27, 2000FDA decision date
QUALICODE B. BURGDORFERI IGM WESTERN BLOT KIT, MODEL DK-C062-024K991062 · LSRImmunetics, Inc.510(k)Sep 21, 1999FDA decision date
QUALICODE B. BURGDORFERI IGG WESTERN BLOT KIT, MODEL DK-C052-024K991063 · LSRImmunetics, Inc.510(k)Sep 21, 1999FDA decision date
BORRELIA BURGDORFERI IGG WESTERN BLOT TEST SYSTEMK991180 · LSRZeus Scientific, Inc.510(k)Sep 3, 1999FDA decision date
BORRELIA BURGDORFERI IGM WESTERN BLOT TEST SYSTEMK991185 · LSRZeus Scientific, Inc.510(k)Sep 3, 1999FDA decision date
QUANTA LITE LYME IGG ELISAK984222 · LSRInova Diagnostics, Inc.510(k)Apr 15, 1999FDA decision date
QUANTA LITE LYME IGM ELISAK984234 · LSRInova Diagnostics, Inc.510(k)Apr 15, 1999FDA decision date
APTUS (AUTOMATED) APPLICATION FOR THE B. BURGDORFERI ANTIBODY ELISA TEST SYSTEMK984138 · LSRZeus Scientific, Inc.510(k)Mar 23, 1999FDA decision date
BBI-BIOTECH RESEARCH LABORATORIES B. BURGDORFERI IGM WESTERN BLOT KITK980351 · LSRBoston Biomedica, Inc.510(k)Mar 5, 1999FDA decision date
PREVUE(TM) BORRELIA BURGDORFERI ANTIBODY DETECTION ASSAYK981913 · LSRChembio Diagnostic Systems, Inc.510(k)Feb 12, 1999FDA decision date
IS BORRELIA BURGDORFERI IGG/IGM ELISA TEST SYSTEMK983605 · LSRColumbia Bioscience, Inc.510(k)Dec 16, 1998FDA decision date
IS BORRELIA BURGDORFERI IGM TEST SYSTEMK983606 · LSRColumbia Bioscience, Inc.510(k)Dec 16, 1998FDA decision date
LYME DISEASE B. BURGDORFERI GENOGROUP 1 WESTERN BLOT IGG (WB0400G)K971006 · LSRMrl Diagnostics510(k)Jun 1, 1998FDA decision date
LYME DISEASE B. BURGDORFERI GENOGROUP 1 WESTERN BLOT IGM (WB0400M)K971007 · LSRMrl Diagnostics510(k)Jun 1, 1998FDA decision date
LIMITED HUMAN LYME IGG WESTERN BLOT KIT (CAMBRIDGE DIAGNOSTICS IRELAND)K970761 · LSRCambridge Diagnostics Ireland, Ltd.510(k)Apr 9, 1998FDA decision date
HUMAN LYME IGM WESTERN BLOT KITK970768 · LSRCambridge Diagnostics Ireland, Ltd.510(k)Apr 9, 1998FDA decision date
CAMBRIDGE BIOTECH HUMAN LYME IGG WESTERN BLOT (90111)K971169 · LSRCambridge Biotech Corp.510(k)Feb 17, 1998FDA decision date
CAMBRIDGE BIOTECH HUMAN LYME IGM WESTERN BLOT (90112)K971170 · LSRCambridge Biotech Corp.510(k)Feb 17, 1998FDA decision date
ACCURUN(TM) 130 BORRELIA BURGDORFERI IGG POSITIVE CONTROLK974809 · LSRBoston Biomedica, Inc.510(k)Feb 5, 1998FDA decision date
ACCURUN(TM) 132 BORRELIA BURDORFERI IGM POSITIVE CONTROLK974810 · LSRBoston Biomedica, Inc.510(k)Feb 5, 1998FDA decision date
BORRELIA BURGDORFERI IGM ELISA TEST SYSTEMK965129 · LSRWampole Laboratories510(k)Mar 26, 1997FDA decision date
BORRELIA BURGDORFERI IGG/IGM ELISA TEST SYSTEMK965131 · LSRWampole Laboratories510(k)Mar 26, 1997FDA decision date
MARDX LYME DISEASE (IGM) MARBLOT STRIP TEST SYSTEMK951709 · LSRMardx Diagnostics, Inc.510(k)Jun 7, 1996FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗